The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: colchicine     Quarter: 2016Q3

Total Drug/Injury Combinations: 179     Number of Pages: 9

DRUGNAME PT EventCount
COLCHICINE. Blood bilirubin increased 1 view events
COLCHICINE. Blood pressure fluctuation 1 view events
COLCHICINE. Caesarean section 1 view events
COLCHICINE. Cardiac disorder 1 view events
COLCHICINE. Cardiac failure congestive 1 view events
COLCHICINE. Cardiac valve disease 1 view events
COLCHICINE. Cardiogenic shock 1 view events
COLCHICINE. Cataract 1 view events
COLCHICINE. Cholelithiasis 1 view events
COLCHICINE. Cholestasis 1 view events
COLCHICINE. Chromaturia 1 view events
COLCHICINE. Chronic kidney disease 1 view events
COLCHICINE. Clostridium difficile infection 1 view events
COLCHICINE. Colitis 1 view events
COLCHICINE. Complicated fracture 1 view events
COLCHICINE. Complication associated with device 1 view events
COLCHICINE. Condition aggravated 1 view events
COLCHICINE. Confusional state 1 view events
COLCHICINE. Congenital central nervous system anomaly 1 view events
COLCHICINE. Dehydration 1 view events

Total Drug/Injury Combinations: 179     Number of Pages: 9

NOTE: EventCount numbers on this page include duplicate entries from event reports. (e.g. One event has DrugX entered twice, which equals 2 on this page.) The "view events" page treats these duplicates as single entries. (e.g. The 2 entries of DrugX for a single event are counted as 1 instance.)